Skip to main content
Home
About
Risks
News
Forums
Groups
Maps
Maps-new
Maps-old
Resources
Articles, Reports
Contacts
Links
Map Your Neighborhood
Resource Topics
Resource nodes
Systems
Dashboards
User login
Username
*
Password
*
Create new account
Request new password
lake
What is the weather on the sun
Search form
Search
Language
Anonymous's groups in this site
User is not a member of any group.
Your groups across all your sites
User is not a member of any group.
Recent Content
CDC assessment of risk to United States from clade I mpox outbreak in Africa
Republicans are also working to Trump-proof their district's federal climate control funding
How some commuinities cope with child poverty after child tax credit expired
U.S. Medical boards almost never discipline doctors who peddle false COVID claims-- research
Many more U.S. seniors are getting COVID shots this year -- CDC
Recent Comments
WHO convening meeting to discuss Mpox status in Africa
4 days 13 hours ago
Writing is on the wall for the US at COP29 --BBC
5 days 11 hours ago
Update: Biden announced vaccine doses and cash for Africa
1 month 3 weeks ago
Florida's new COVID booster guidance called misinformation
1 month 3 weeks ago
Who's online
There are currently 0 users online.
You are here
Home
Treatments
FDA asks Pfizer to test second Paxlovid course in patients with COVID rebound
Fri, 2022-08-19 16:38 —
mike kraft
FDA asks Pfizer to test second Paxlovid course in patients with COVID rebound
The U.S. Food and Drug Administration (FDA) has ordered Pfizer Inc to test the effects of an additional course of its antiviral Paxlovid among people who experience a rebound in COVID-19 after treatment, the regulator said on Friday.
Reuters
Reuters
...
Country / Region Tags:
United States
General Topic Tags:
COVID-19
Treatments
Disease
Disease Prevention
Government
Health
Medical Testing
Mutations
Pandemics
Public Health
Research
Problem, Solution, SitRep, or ?:
Situation Report
Read more
about FDA asks Pfizer to test second Paxlovid course in patients with COVID rebound
Log in
or
register
to post comments
U.S. Covid costs for vaccines and treatment to shift to patients and insurers
Fri, 2022-08-19 13:19 —
mike kraft
COVID costs could fall on insurers and consumers
HHS has a meeting scheduled later this month with drugmakers, pharmacies, and state health departments to address the changes.
Arielle Dreher
Axios
Country / Region Tags:
United States
General Topic Tags:
COVID-19
Boosters
Treatments
Contagion
Disease
Disease Prevention
Government
Health
Pandemics
Policy
Public Health
Vaccinations
Problem, Solution, SitRep, or ?:
Situation Report
Read more
about U.S. Covid costs for vaccines and treatment to shift to patients and insurers
Log in
or
register
to post comments
How to assess risk for long term Covid issues--CNN
Fri, 2022-08-19 09:56 —
mike kraft
Long Covid risk extends two years after infection. Here's how to assess your risk
A new study found an increased risk of certain long Covid-19 symptoms up to two years after an original infection.
Sandee LaMotte, CNN
CNN
Country / Region Tags:
Global
United States
General Topic Tags:
COVID-19
Symptoms
Treatments
Disease
Disease Prevention
Mutations
Pandemics
Public Health
Research
Problem, Solution, SitRep, or ?:
Analysis
Read more
about How to assess risk for long term Covid issues--CNN
Log in
or
register
to post comments
Ebola: WHO recommends use of two antibody drugs against Ebola
Fri, 2022-08-19 09:10 —
mike kraft
WHO recommends use of two antibody drugs against Ebola
The World Health Organization (WHO) on Friday recommended two monoclonal antibody treatments against Ebola, saying the use of such drugs combined with better care had "revolutionised" the treatment of a disease once seen as a near-certain killer.
Reuters
Reuters
...
Country / Region Tags:
Africa
Conakry
Ghana
Guinea
Liberia
Nigeria
Sierra Leone
South Africa
United Nations
General Topic Tags:
Treatments
Contagion
Disease
Disease Prevention
Health
Public Health
Research
Science
Problem, Solution, SitRep, or ?:
Situation Report
Read more
about Ebola: WHO recommends use of two antibody drugs against Ebola
Log in
or
register
to post comments
Pages
« first
‹ previous
…
58
59
60
61
62
63
64
65
66
howdy folks
Page loaded in 0.623 seconds.
Recent Comments